Cristin Rothfuss - Nov 26, 2024 Form 3 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
EVP, General Counsel
Signature
/s/ Cristin Rothfuss
Stock symbol
SRPT
Transactions as of
Nov 26, 2024
Transactions value $
$0
Form type
3
Date filed
11/29/2024, 08:00 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SRPT Common Stock 11.8K Nov 26, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SRPT Stock Option (Right to buy) Nov 26, 2024 Common Stock 5.05K $133.76 Direct F1
holding SRPT Stock Option (Right to buy) Nov 26, 2024 Common Stock 216 $90.15 Direct F1
holding SRPT Stock Option (Right to buy) Nov 26, 2024 Common Stock 2.53K $114.47 Direct F1
holding SRPT Stock Option (Right to buy) Nov 26, 2024 Common Stock 1.2K $118.52 Direct F1
holding SRPT Stock Option (Right to buy) Nov 26, 2024 Common Stock 1.56K $87.11 Direct F1
holding SRPT Stock Option (Right to buy) Nov 26, 2024 Common Stock 1.25K $87.11 Direct F1
holding SRPT Stock Option (Right to buy) Nov 26, 2024 Common Stock 4.2K $80.42 Direct F1
holding SRPT Stock Option (Right to buy) Nov 26, 2024 Common Stock 5.9K $155.99 Direct F1
holding SRPT Stock Option (Right to buy) Nov 26, 2024 Common Stock 6.2K $128.67 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the date upon which the first twenty-five percent of the option granted vests. 1/48th of the total granted option vests and becomes exercisable on each monthly anniversary thereafter.